Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 55555041500
SciProfiles: 1493273
Scopus Author ID: 57661104900

Activities

Collapse all

Employment (2)

University Hospitals Birmingham NHS Foundation Trust: Birmingham, Birmingham, GB

2011-10 to present | Consultant Respiratory Physician (Respiratory medicine)
Employment
Source: Self-asserted source
Alice Turner

University of Birmingham: Birmingham, Birmingham, GB

2006-05 to present | Reader in respiratory medicine (Institute of Applied Health Research)
Employment
Source: Self-asserted source
Alice Turner

Education and qualifications (3)

University of Birmingham: Birmingham, Birmingham, GB

2006-05 to 2009-02 | PhD (Clinical and Experimental Medicine)
Education
Source: Self-asserted source
Alice Turner

University of Dundee: Dundee, Dundee, GB

2005-12 to 2007-09 | PGCE (Medical Education)
Education
Source: Self-asserted source
Alice Turner

University of Leicester: Leicester, Leicester, GB

1996-09 to 2001-07 | MBChB (Hons)
Education
Source: Self-asserted source
Alice Turner

Professional activities (3)

British Thoracic Society: London, GB

2019 to 2022 | Quality Improvement committee member
Service
Source: Self-asserted source
Alice Turner

National Institute for Health and Care Excellence: London, London, GB

2018-06 to 2021-06 | Health Technology Appraisal committee member (Health Technology Appraisal)
Service
Source: Self-asserted source
Alice Turner

British Thoracic Society: London, GB

2015 to 2018 | COPD specialist advisory committee member
Service
Source: Self-asserted source
Alice Turner

Funding (29)

Midlands Patient Safety Research Centre

2023-04 to 2028-04 | Award
National Institute for Health Research (London, GB)
Source: Self-asserted source
Alice Turner

STABILISE: a multicentre, double-blind, randomised, parallel group, superiority trial to investigate the use of BCG vaccine in altering immune response and exacerbation in chronic obstructive pulmonary disease (COPD)

2022-12 to 2026-12 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Alice Turner

Air quality supersite triplets (UK-AQST)

2021-01-22 to 2023-02-21 | Grant
Natural Environment Research Council (Swindon, GB)
URL: https://app.dimensions.ai/details/grant/grant.9555573
GRANT_NUMBER: NE/V017624/1
Source: Self-asserted source
Alice Turner via DimensionsWizard

Airway microbiome driven mechanisms of disease after optimised self management: Colour-COPD trial

2021-01-01 to 2024-12-31 | Grant
NIHR Evaluation Trials and Studies Coordinating Centre (Southampton, GB)
URL: https://app.dimensions.ai/details/grant/grant.9613485
GRANT_NUMBER:

NIHRDH-NIHR130938
Source: Self-asserted source
Alice Turner via DimensionsWizard

Ambulatory oxygen for pulmonary fibrosis (OxyPuF)

2020-11-01 to 2023-10-31 | Grant
NIHR Evaluation Trials and Studies Coordinating Centre (Southampton, GB)
URL: https://app.dimensions.ai/details/grant/grant.9613516
GRANT_NUMBER: NIHR131149
Source: Self-asserted source
Alice Turner via DimensionsWizard

Air Pollution Solutions for Vulnerable Groups (CleanAir4V)

2020-08-31 to 2023-08-30 | Grant
Natural Environment Research Council (Swindon, GB)
URL: https://app.dimensions.ai/details/grant/grant.9401852
GRANT_NUMBER: NE/V002414/1
Source: Self-asserted source
Alice Turner via DimensionsWizard

Stopping anticoagulation for isolated or incidental sub-segmental pulmonary embolism (STOPAPE)

2019-12-01 to 2024-05-31 | Grant
NIHR Evaluation Trials and Studies Coordinating Centre (Southampton, GB)
URL: https://app.dimensions.ai/details/grant/grant.9249657
GRANT_NUMBER:

NIHRDH-NIHR128073
Source: Self-asserted source
Alice Turner via DimensionsWizard

Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of COPD (Colour-COPD)

2019-12-01 to 2023-11-30 | Grant
NIHR Evaluation Trials and Studies Coordinating Centre (Southampton, GB)
URL: https://app.dimensions.ai/details/grant/grant.9714590
GRANT_NUMBER: 17/128/04
Source: Self-asserted source
Alice Turner via DimensionsWizard

A Personalised Early Warning Decision Support System with novel Saliva Bio-Profiling to Predict and Prevent Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Predict&Prevent AECOPD)

2019-04 to 2022-04 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Alice Turner

Estimating prevalence of AATD patients potentially eligible for augmentation therapy in the UK

2019-02 to 2020-02 | Grant
CSL Behring (Basel, CH)
Source: Self-asserted source
Alice Turner

Nudging more cost effective medication use across NHS organisations

2018-12 to 2021-12 | Grant
Health Foundation (London, GB)
Source: Self-asserted source
Alice Turner

The importance of small airway dysfunction and its assessment in older patients with airflow obstruction (SAFRON)

2018-11 to 2020-11 | Grant
Chiesi Farmaceutici (Parma, IT)
Source: Self-asserted source
Alice Turner

Causes of failure of opsonophagocytosis of non-typeable haemophilus influenzae in AATD’

2018-09 to 2020-09 | Grant
Alpha One Foundation (Miami, US)
Source: Self-asserted source
Alice Turner

Improving access to augmentation therapy in AATD: the effect of augmentation on quality of life’

2018-06 to 2020-06 | Grant
ATS Foundation (New York, US)
Source: Self-asserted source
Alice Turner

Clinical utility of MRI imaging of the lung in AATD’

2017-10 to 2019-10 | Grant
Chest foundation (Chicago, US)
Source: Self-asserted source
Alice Turner

Proteomic signatures of COPD severity and progression in AATD

2017-07 to 2020-07 | Grant
Alpha One Foundation (Miami, US)
Source: Self-asserted source
Alice Turner

The impact of specialist led integrated care on guideline adherence and outcomes in COPD’

2017-06 to 2020-12 | Grant
AstraZeneca (London, GB)
Source: Self-asserted source
Alice Turner

BREATHEWELL –Improving diagnosis, management & prognosis of COPD in primary care in LMIC countries

2017-04 to 2020-04 | Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Alice Turner

Improving access to augmentation therapy: a propensity matching study between the UK AATD registry and AlphaNet

2016-10 to 2017-10 | Contract
AlphaNet (Miami, US)
Source: Self-asserted source
Alice Turner

Elastin degradation in exacerbations of AATD lung disease

2016-09 to 2019-08 | Grant
Alpha-1 Foundation (FL, FL, US)
Source: Self-asserted source
Alice Turner

Improving access to augmentation therapy: a propensity matching study between the UK AATD registry and AlphaNet

2016-09 to 2017-09 | Grant
Chest Foundation (IL, IL, US)
Source: Self-asserted source
Alice Turner

Automated Conflict Resolution in Clinical Pathways

2015-07-31 to 2018-07-30 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
URL: https://grants.uberresearch.com/501100000266/5342B2BB-63FE-4509-89DD-5E7F3044D0B6/Automated-Conflict-Resolution-in-Clinical-Pathways
GRANT_NUMBER: EP/M014401/1
Source: Self-asserted source
Alice Turner via DimensionsWizard

Treatment and prognosis in AATD: a systematic review and patient centred model

2015-03 to 2019-08 | Grant
National Institute for Health Research Public Health Practice Evaluation Scheme (London, GB)
Source: Self-asserted source
Alice Turner

PI3K Signaling and Aberrant Neutrophil Function in COPD; Implications for Disease Susceptibility, Prognosis and Therapeutic Targeting

Source: Self-asserted source
Alice Turner via DimensionsWizard

Function of genetic modifiers in AATD lung disease

2014-01 to 2016-01 | Grant
Alpha-1 Foundation (FL, FL, US)
Source: Self-asserted source
Alice Turner

Clinical effectiveness and cost-effectiveness of community based NIV in patients with stable end stage COPD with hypercapnic respiratory failure: a systematic review and economic evaluation

2012-10 to 2014-03 | Grant
National Institute for Health Research Public Health Practice Evaluation Scheme (London, GB)
Source: Self-asserted source
Alice Turner

Exome determinants of lung function in Alpha 1

2012-07 to 2016-06 | Grant
Alpha-1 Foundation (FL, FL, US)
Source: Self-asserted source
Alice Turner

Can muscle dysfunction in COPD be altered by oxygenation? A pilot RCT

2011-11 to 2014-11 | Grant
Linde real fund (Munich, DE)
Source: Self-asserted source
Alice Turner

COPD in primary care: from case finding to improving patient outcomes (BLISS)

Grant
National Institute for Health Research Public Health Practice Evaluation Scheme (London, GB)
GRANT_NUMBER: RP-PG-0109-10061
Source: Self-asserted source
Alice Turner

Peer review (58 reviews for 30 publications/grants)

Review activity for Alimentary pharmacology & therapeutics. (1)
Review activity for Biomedicines. (1)
Review activity for BMJ open respiratory research. (4)
Review activity for BMJ open. (1)
Review activity for Cells. (2)
Review activity for Cellular & Molecular Biology Letters. (1)
Review activity for COPD : (1)
Review activity for Diagnostics. (2)
Review activity for ERJ open research. (2)
Review activity for European respiratory journal. (6)
Review activity for Expert opinion on investigational drugs (1)
Review activity for Expert review of respiratory medicine. (2)
Review activity for International journal of COPD (3)
Review activity for International journal of environmental research and public health (4)
Review activity for International journal of molecular sciences. (2)
Review activity for Journal of clinical medicine. (2)
Review activity for Journal of personalized medicine. (1)
Review activity for Journal of respiration. (1)
Review activity for Medicina. (1)
Review activity for Minerva medica. (1)
Review activity for Molecules. (1)
Review activity for Oxygen. (2)
Review activity for Perfusion. (1)
Review activity for Respiratory care : (1)
Review activity for SAGE open medical case reports. (1)
Review activity for The clinical respiratory journal. (4)
Review activity for Therapeutic advances in chronic disease. (1)
Review activity for Therapeutic advances in respiratory disease (1)
Review activity for Thorax (6)
Review activity for Toxics. (1)
How many people are using ORCID?